1. Home
  2. CPSS vs PEPG Comparison

CPSS vs PEPG Comparison

Compare CPSS & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$9.30

Market Cap

201.1M

Sector

Finance

ML Signal

N/A

Logo PepGen Inc.

PEPG

PepGen Inc.

N/A

Current Price

$3.42

Market Cap

207.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPSS
PEPG
Founded
1991
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.1M
207.1M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
CPSS
PEPG
Price
$9.30
$3.42
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.17
AVG Volume (30 Days)
15.2K
993.6K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
25.61
EPS
0.50
N/A
Revenue
$434,470,000.00
N/A
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.32
N/A
Revenue Growth
10.41
N/A
52 Week Low
$6.67
$1.13
52 Week High
$10.49
$7.80

Technical Indicators

Market Signals
Indicator
CPSS
PEPG
Relative Strength Index (RSI) 48.70 74.97
Support Level $9.29 $1.50
Resistance Level $9.40 $7.10
Average True Range (ATR) 0.25 0.22
MACD -0.02 0.04
Stochastic Oscillator 35.48 98.35

Price Performance

Historical Comparison
CPSS
PEPG

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: